| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/12/2008 | CN101139591A Small molecule RNA of shark liver and use thereof |
| 03/12/2008 | CN101139390A Pig gamma interferon and encoding genes and use thereof |
| 03/12/2008 | CN101138637A Antineoplastic medicament and adenovirus composite preparations and uses thereof |
| 03/12/2008 | CN101138636A Gene medicine conveying system and method of preparing the same |
| 03/12/2008 | CN100374574C Stable adenoviral vectors and methods for propagation thereof |
| 03/12/2008 | CN100374573C Carrier PCD-VEGF able to stable express VEGF shRNA |
| 03/12/2008 | CN100374563C Attenuated pestiviruses |
| 03/12/2008 | CN100374559C Protease subunit C3 of clonorchis sinensis, its coding nucleic acid and application |
| 03/12/2008 | CN100374551C Compositions comprising viruses and methods for concentrating virus preparations |
| 03/12/2008 | CN100374164C Recombinant plasmid for curing prostate gland cancer and melanoma |
| 03/12/2008 | CN100374152C Hypersensitivity reaction inhibitor |
| 03/12/2008 | CN100374085C Method and apparatus for production of a skin graft and the graft produced thereby |
| 03/11/2008 | US7342111 Adeno-associated virus-delivered ribozyme compositions and methods of use |
| 03/11/2008 | US7342108 De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof |
| 03/11/2008 | US7342002 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy |
| 03/11/2008 | US7341995 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 03/11/2008 | US7341871 Recombinant expression vector comprising promoter sequence, age regulatory sequence; can use in treatment of age-related and liver diseases; operably linking nucleic acid sequence, promoter sequence, and age regulatory sequences to produce a transgene, introducing into cell |
| 03/11/2008 | US7341869 Compositions and methods for treating diabetes |
| 03/11/2008 | US7341866 Gene expression patterns; diagnosis, therapy disease |
| 03/11/2008 | US7341864 Apparatus for use in the transfer of nucleotide sequences in to cells |
| 03/11/2008 | US7341847 Promoter construct for gene expression in neuronal cells |
| 03/11/2008 | US7341738 Lipid-encapsulated polyanionic nucleic acid |
| 03/11/2008 | US7341719 Myoblast therapy for cosmetic treatment |
| 03/11/2008 | US7341718 Neuronal gene transfer of adenovirus and herpes virus vectors |
| 03/11/2008 | US7341717 Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor |
| 03/11/2008 | CA2444561C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 03/11/2008 | CA2391647C Biomolecular complex formed between hyaluronic acid and a biomolecule |
| 03/11/2008 | CA2270396C Cationic reagents for transfection |
| 03/11/2008 | CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 03/08/2008 | CA2622504A1 Methods and compositions for inhibiting cell death or enhancing cel proliferation |
| 03/06/2008 | WO2008027456A2 Methods, compositions and kits relating to antigen presenting tumor cells |
| 03/06/2008 | WO2008027210A2 Biocompatible stent |
| 03/06/2008 | WO2008026869A1 A dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein |
| 03/06/2008 | WO2008025163A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 03/06/2008 | WO2008025160A1 Oxepane nucleosides and oligonucleotides, uses thereof and methods of making the same |
| 03/06/2008 | WO2008025073A1 Method of modulation of expression of epidermal growth factor receptor (egfr) involving mirna |
| 03/06/2008 | WO2008025069A1 Methods of modulating cellular activity and compositions therefor |
| 03/06/2008 | WO2008006458A3 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them |
| 03/06/2008 | WO2008004972A3 Use of nucleic acid sequences for the treatment of neurological and psychiatric diseases, vectors and compositions |
| 03/06/2008 | WO2007134132A3 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 03/06/2008 | WO2007104792A3 Recombinant adenoviruses based on serotype 26 and 48, and use thereof |
| 03/06/2008 | WO2007092944A3 Compositions and methods involving gene therapy and proteasome modulation |
| 03/06/2008 | WO2006122971A3 Treatment of disease using an improved regulated expression system |
| 03/06/2008 | US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders |
| 03/06/2008 | US20080058279 Such as 3-[4-(2-Octadec-9-enyloxycarbonyl-ethylamino)-butylamino]-propionic acid octadec-9-enyl ester dihydrochloride salt; use with vectors for in vivo transfection |
| 03/06/2008 | US20080058278 Reduce oxygen toxicity in lung diseases, dysplasia in premature infants; plasmid for coding sequence |
| 03/06/2008 | US20080058277 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression |
| 03/06/2008 | US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents |
| 03/06/2008 | US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators |
| 03/06/2008 | US20080058258 Growth Factor |
| 03/06/2008 | US20080058247 Polynucleotides and Polypeptides Encoding Receptors |
| 03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057510 Human Vascular IBP-Like Growth Factor |
| 03/06/2008 | US20080057509 Defects in Periaxin Associated with Myelinopathies |
| 03/06/2008 | US20080057096 Comprising stent body, first layer applied over stent body comprising a therapeutic substance and second layer applied over first layer comprising a fluoride-containing hydrophilic water insoluble crosslinked resin; biocompatible layer leaches fluoride to provide further therapy to patient |
| 03/06/2008 | US20080057077 Tumour-associated peptides binding to mhc-molecules |
| 03/06/2008 | US20080057076 Novel fibroblast growth factors |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
| 03/06/2008 | US20080057046 Lactic acid producing bacteria for use as probiotic organisms in the human vagina |
| 03/06/2008 | US20080057036 comprising a Picornavirus capable of lytically infecting or killing a cell substantially in the absence of intercellular adhesion molecule |
| 03/06/2008 | US20080057035 Methods of treating various cancers using melanoma differentiation associated protein-7 |
| 03/06/2008 | US20080057006 genetic vaccines comprising a recombination activating gene (rag) nucleotide sequence, used to code polypeptides, for the prevention and/or treatment of periodontal diseases, caused by infection by Porphyromonas gingivalis |
| 03/06/2008 | CA2662026A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 03/05/2008 | EP1895010A2 Equine infectious anaemia virus (eiav) based vectors |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1895003A1 Cells expressing recombinase |
| 03/05/2008 | EP1893750A1 Amniotic cells and methods for use thereof |
| 03/05/2008 | EP1893650A2 Hiv tat-cd4 hybried molecules and methods of use thereof |
| 03/05/2008 | EP1583504A4 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 03/05/2008 | EP1558086A4 Cell targeting methods and compositions |
| 03/05/2008 | EP1292289B1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 03/05/2008 | EP1282710B1 Fish vaccine against piscirickettsia salmonis |
| 03/05/2008 | EP1144609B1 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/05/2008 | CN101137755A Method for gene delivery to neuronal cells |
| 03/05/2008 | CN101134966A Modified nucleic acid sequences and method to increasing mrna levels and protein expression in cell systems |
| 03/05/2008 | CN101134110A Q type non-viral vector and pharmaceutical composition containing the same |
| 03/05/2008 | CN100373375C System and method for controlling user interface attribute by data |
| 03/05/2008 | CN100372932C Positive regulation gene for cell cycle and its coded protein and uses |
| 03/05/2008 | CN100372572C Recombinant plasmid with human thymosin Beta-4gene |
| 03/04/2008 | US7339051 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339042 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors |
| 03/04/2008 | US7339037 nucleoside sequence polypeptides; therapy, prevention of influenza viral infections |
| 03/04/2008 | US7339030 Human semaphorin L (H-SemaL) and corresponding semaphorins in other species |
| 03/04/2008 | US7339029 Sperm-specific cation channel, CatSper2, and uses therefor |
| 03/04/2008 | US7338931 Administering a hyaluronic acid and an insulin for treating diabetes; structure compacted due to the passing of the structure over its point of collapse with buried polar groups and a minimum size; the hyaluronic acid surrounds the insulin |
| 03/04/2008 | US7338929 Cancer immunotherapy |
| 03/04/2008 | US7338799 Polynucleotide encoding a mouse choline transporter |
| 03/04/2008 | US7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 |
| 03/04/2008 | US7338656 Composition and method to alter lean body mass and bone properties in a subject |
| 03/04/2008 | US7338655 Generating a recombinant viral or plasmid vector; transfecting in vitro a population of chondrocytes with recombinant vector, transplanting transfected chondrocytes without scaffolding by intraarticular injection to an osteoarthritic joint space for regenerating hyaline cartilage |
| 03/01/2008 | CA2598060A1 Methods and compositions for the treatment and prevention of cancer |
| 03/01/2008 | CA2597840A1 Methods and compositions for the treatment and prevention of cancer |
| 02/28/2008 | WO2008025025A2 Antisense composition and method for inhibition of mirna biogenesis |
| 02/28/2008 | WO2008024844A2 Anticancer combination therapies |
| 02/28/2008 | WO2008024300A1 SEMAPHORIN 7A PLAYS A CRITICAL ROLE IN TGF-β1-INDUCED PULMONARY FIBROSIS AND ALVEOLAR DESTRUCTION |
| 02/28/2008 | WO2008024242A2 Use of cd83 in combination therapies |
| 02/28/2008 | WO2008023947A1 A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma |